Vanguard Group Inc Neuroone Medical Technologies Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Vanguard Group Inc holds 919,528 shares of NMTC stock, worth $643,669. This represents 0.0% of its overall portfolio holdings.
Number of Shares
919,528
Previous 919,528
-0.0%
Holding current value
$643,669
Previous $735,000
23.81%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NMTC
# of Institutions
22Shares Held
2.42MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT799KShares$559,1330.05% of portfolio
-
Geode Capital Management, LLC Boston, MA284KShares$198,6980.0% of portfolio
-
Perkins Capital Management Inc150KShares$105,0000.15% of portfolio
-
State Street Corp Boston, MA59.5KShares$41,6490.0% of portfolio
-
Blair William & CO Chicago, IL55.6KShares$38,8890.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $11.3M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...